메뉴 건너뛰기




Volumn 13, Issue 2, 2006, Pages 215-222

The emergency department: First line of defense in preventing secondary stroke

Author keywords

Guidelines; Ischemic; Prevention; Stroke; TIA

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CANDESARTAN HEXETIL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; THIAZIDE DIURETIC AGENT; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

EID: 31544453926     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2005.07.035     Document Type: Article
Times cited : (16)

References (53)
  • 2
    • 0034645547 scopus 로고    scopus 로고
    • Short-term prognosis after ED diagnosis of TIA
    • S. Johnston, D.R. Gress, W.S. Browner, and S. Sidney Short-term prognosis after ED diagnosis of TIA JAMA 284 2000 2901 2906
    • (2000) JAMA , vol.284 , pp. 2901-2906
    • Johnston, S.1    Gress, D.R.2    Browner, W.S.3    Sidney, S.4
  • 3
    • 1842610714 scopus 로고    scopus 로고
    • Current and future concepts in stroke prevention
    • F. O'Rourke, N. Dean, N. Akhtar, and A. Shuaib Current and future concepts in stroke prevention CMAJ 170 2004 1123 1133
    • (2004) CMAJ , vol.170 , pp. 1123-1133
    • O'Rourke, F.1    Dean, N.2    Akhtar, N.3    Shuaib, A.4
  • 5
    • 0035170373 scopus 로고    scopus 로고
    • Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham Study
    • N.S. Rost, P.A. Wolf, and C.S. Kase Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study Stroke 32 2001 2575 2579
    • (2001) Stroke , vol.32 , pp. 2575-2579
    • Rost, N.S.1    Wolf, P.A.2    Kase, C.S.3
  • 6
    • 0037078969 scopus 로고    scopus 로고
    • Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
    • P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
    • (2002) N Engl J Med , vol.347 , pp. 1557-1565
    • Ridker, P.M.1    Rifai, N.2    Rose, L.3    Buring, J.E.4    Cook, N.R.5
  • 7
    • 0037130648 scopus 로고    scopus 로고
    • New evidence for stroke prevention: Scientific review
    • S.E. Straus, S.R. Majumdar, and F.A. McAlister New evidence for stroke prevention: scientific review JAMA 288 2002 1388 1395
    • (2002) JAMA , vol.288 , pp. 1388-1395
    • Straus, S.E.1    Majumdar, S.R.2    McAlister, F.A.3
  • 8
    • 1442348268 scopus 로고    scopus 로고
    • Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study
    • K. Hardie, G.J. Hankey, K. Jamrozik, R.J. Broadhurst, and C. Anderson Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study Stroke 35 2004 731 735
    • (2004) Stroke , vol.35 , pp. 731-735
    • Hardie, K.1    Hankey, G.J.2    Jamrozik, K.3    Broadhurst, R.J.4    Anderson, C.5
  • 9
    • 3242753184 scopus 로고    scopus 로고
    • Excess stroke in Mexican Americans compared with non-Hispanic whites: The Brain Attack Surveillance in Corpus Christi Project
    • L.B. Morgenstern, M.A. Smith, and L.D. Lisabeth Excess stroke in Mexican Americans compared with non-Hispanic whites: the Brain Attack Surveillance in Corpus Christi Project Am J Epidemiol 160 2004 376 383
    • (2004) Am J Epidemiol , vol.160 , pp. 376-383
    • Morgenstern, L.B.1    Smith, M.A.2    Lisabeth, L.D.3
  • 10
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham study
    • P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 1991 983 988
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 11
    • 0023845614 scopus 로고
    • Cigarette smoking as a risk factor for stroke. the Framingham study
    • P.A. Wolf, R.B. D'Agostino, W.B. Kannel, R. Bonita, and A.J. Belanger Cigarette smoking as a risk factor for stroke. The Framingham study JAMA 259 1988 1025 1029
    • (1988) JAMA , vol.259 , pp. 1025-1029
    • Wolf, P.A.1    D'Agostino, R.B.2    Kannel, W.B.3    Bonita, R.4    Belanger, A.J.5
  • 12
    • 0036214641 scopus 로고    scopus 로고
    • Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease
    • B.G. Vickrey, T.S. Rector, and S.L. Wickstrom Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease Stroke 33 2002 901 906
    • (2002) Stroke , vol.33 , pp. 901-906
    • Vickrey, B.G.1    Rector, T.S.2    Wickstrom, S.L.3
  • 13
    • 0037264340 scopus 로고    scopus 로고
    • Experts want TIAs redefined
    • L.H. Schwamm Experts want TIAs redefined Health News 9 2003 1 2
    • (2003) Health News , vol.9 , pp. 1-2
    • Schwamm, L.H.1
  • 14
    • 0037153037 scopus 로고    scopus 로고
    • Transient ischemic attack - Proposal for a new definition
    • G.W. Albers, L.R. Caplan, and J.D. Easton the TIA Working Group Transient ischemic attack - proposal for a new definition N Engl J Med 347 2002 1713 1716
    • (2002) N Engl J Med , vol.347 , pp. 1713-1716
    • Albers, G.W.1    Caplan, L.R.2    Easton, J.D.3
  • 15
    • 0242525103 scopus 로고    scopus 로고
    • Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today?
    • P.A.G. Sandercock Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today? J Neurol Neurosurg Psychiatry 74 2003 1461 1464
    • (2003) J Neurol Neurosurg Psychiatry , vol.74 , pp. 1461-1464
    • Sandercock, P.A.G.1
  • 17
    • 0036716805 scopus 로고    scopus 로고
    • Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attack
    • J.S. Elkins, S. Sidney, D.R. Gress, A.S. Go, A.L. Bernstein, and S.C. Johnston Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attack Arch Neurol 59 2002 1437 1441
    • (2002) Arch Neurol , vol.59 , pp. 1437-1441
    • Elkins, J.S.1    Sidney, S.2    Gress, D.R.3    Go, A.S.4    Bernstein, A.L.5    Johnston, S.C.6
  • 18
    • 0037262139 scopus 로고    scopus 로고
    • Long-term outcome after ischaemic stroke/transient ischaemic attack
    • G.J. Hankey Long-term outcome after ischaemic stroke/transient ischaemic attack Cerebrovasc Dis 16 Suppl 1 2003 14 19
    • (2003) Cerebrovasc Dis , vol.16 , Issue.SUPPL. 1 , pp. 14-19
    • Hankey, G.J.1
  • 19
    • 18844477380 scopus 로고    scopus 로고
    • Recommendations for the establishment of primary stroke centers. Brain Attack Coalition
    • M.J. Alberts, G. Hademenos, and R.E. Latchaw Recommendations for the establishment of primary stroke centers. Brain Attack Coalition JAMA 283 2000 3102 3109
    • (2000) JAMA , vol.283 , pp. 3102-3109
    • Alberts, M.J.1    Hademenos, G.2    Latchaw, R.E.3
  • 20
    • 0028783948 scopus 로고
    • Tissue plasminogen activator for acute ischemic stroke
    • National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
    • (1995) N Engl J Med , vol.333 , pp. 1581-1587
  • 21
    • 0033194294 scopus 로고    scopus 로고
    • Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: A statement for healthcare professionals from the Stroke Council of the American Heart Association
    • P.A. Wolf, G.P. Clagett, and J.D. Easton Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association Stroke 30 1999 1991 1994
    • (1999) Stroke , vol.30 , pp. 1991-1994
    • Wolf, P.A.1    Clagett, G.P.2    Easton, J.D.3
  • 22
    • 5344256249 scopus 로고    scopus 로고
    • PROTECT: A coordinated stroke treatment program to prevent recurrent thromboembolic events
    • B. Ovbiagele, J.L. Saver, and A. Fredieu PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events Neurology 63 2004 1217 1222
    • (2004) Neurology , vol.63 , pp. 1217-1222
    • Ovbiagele, B.1    Saver, J.L.2    Fredieu, A.3
  • 23
    • 20044372718 scopus 로고    scopus 로고
    • Recommendations for the establishment of stroke systems of care
    • L.H. Schwamm, A. Pancioli, and J.E. Acker 3rd the American Stroke Association's Task Force on the Development of Stroke Systems Recommendations for the establishment of stroke systems of care Stroke 36 2005 690 703 Epub February 2, 2005
    • (2005) Stroke , vol.36 , pp. 690-703
    • Schwamm, L.H.1    Pancioli, A.2    Acker III, J.E.3
  • 24
    • 11144311142 scopus 로고    scopus 로고
    • Emergency department evaluation of ischemic stroke and TIA: BASIC Project
    • D.L. Brown, L.D. Lisabeth, and N.M. Garcia Emergency department evaluation of ischemic stroke and TIA: BASIC Project Neurology 63 2004 2250 2254
    • (2004) Neurology , vol.63 , pp. 2250-2254
    • Brown, D.L.1    Lisabeth, L.D.2    Garcia, N.M.3
  • 25
    • 4644261801 scopus 로고    scopus 로고
    • Thrombolytic therapy for ischemic stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • G.W. Albers, P. Amarenco, J.D. Easton, R.L. Sacco, and P. Teal Thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 483S 512S
    • (2004) Chest , vol.126
    • Albers, G.W.1    Amarenco, P.2    Easton, J.D.3    Sacco, R.L.4    Teal, P.5
  • 26
    • 0030911057 scopus 로고    scopus 로고
    • The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
    • International Stroke Trial Collaborative Group
    • International Stroke Trial Collaborative Group The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke Lancet 349 1997 1569 1581
    • (1997) Lancet , vol.349 , pp. 1569-1581
  • 27
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antiplatelet Trialists' Collaboration
    • Antiplatelet Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
    • (2002) BMJ , vol.324 , pp. 71-86
  • 28
    • 0030590746 scopus 로고    scopus 로고
    • A randomized, blinded trial of clopidogrel versus aspirin in patients at risk for ischemic events
    • CAPRIE Steering Committee A randomized, blinded trial of clopidogrel versus aspirin in patients at risk for ischemic events Lancet 348 1996 1329 1339
    • (1996) Lancet , vol.348 , pp. 1329-1339
    • Steering Committee, C.1
  • 29
    • 0032848818 scopus 로고    scopus 로고
    • Safety and tolerability of clopidogrel and aspirin: Results from CAPRIE
    • L.A. Harker, J.-P. Boissel, A.J. Pilgrim, and M. Gent Safety and tolerability of clopidogrel and aspirin: results from CAPRIE Drug Saf 21 1999 325 335
    • (1999) Drug Saf , vol.21 , pp. 325-335
    • Harker, L.A.1    Boissel, J.-P.2    Pilgrim, A.J.3    Gent, M.4
  • 30
    • 3242770664 scopus 로고    scopus 로고
    • Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial
    • on behalf of the MATCH Investigators L.M.
    • H.C. Diener, J. Bogousslavsky, L.M. Brass on behalf of the MATCH Investigators Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial Lancet 364 2004 331 337
    • (2004) Lancet , vol.364 , pp. 331-337
    • Diener, H.C.1    Bogousslavsky, J.2    Brass3
  • 31
    • 0030297319 scopus 로고    scopus 로고
    • European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
    • H.C. Diener, L. Cunha, and C. Forbes European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke J Neurol Sci 143 1996 1 13
    • (1996) J Neurol Sci , vol.143 , pp. 1-13
    • Diener, H.C.1    Cunha, L.2    Forbes, C.3
  • 32
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized, controlled trials
    • Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized, controlled trials Arch Intern Med 154 1994 1449 1457
    • (1994) Arch Intern Med , vol.154 , pp. 1449-1457
    • Fibrillation Investigators, A.1
  • 33
    • 0035892035 scopus 로고    scopus 로고
    • A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
    • J.P. Mohr, J.L.P. Thompson, and R.M. Lazar A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke N Engl J Med 345 2001 1444 1451
    • (2001) N Engl J Med , vol.345 , pp. 1444-1451
    • Mohr, J.P.1    Thompson, J.L.P.2    Lazar, R.M.3
  • 34
    • 20144366696 scopus 로고    scopus 로고
    • Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis
    • M.I. Chimowitz, M.J. Lynn, and H. Howlett-Smith Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis N Engl J Med 352 2005 1305 1316
    • (2005) N Engl J Med , vol.352 , pp. 1305-1316
    • Chimowitz, M.I.1    Lynn, M.J.2    Howlett-Smith, H.3
  • 36
    • 0037463824 scopus 로고    scopus 로고
    • Differential effects of lipid-lowering therapies on stroke prevention: A meta-analysis of randomized trials
    • J.-C. Corvol, A. Bouzamondo, M. Sirol, J.-S. Hulot, P. Sanchez, and P. Lechat Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials Arch Intern Med 163 2003 669 676
    • (2003) Arch Intern Med , vol.163 , pp. 669-676
    • Corvol, J.-C.1    Bouzamondo, A.2    Sirol, M.3    Hulot, J.-S.4    Sanchez, P.5    Lechat, P.6
  • 37
    • 1542345696 scopus 로고    scopus 로고
    • Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions
    • Heart Protection Study Collaborative Group R.
    • R. Collins, J. Armitage, S. Parish, P. Sleight, R. Peto Heart Protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Lancet 363 2004 757 767
    • (2004) Lancet , vol.363 , pp. 757-767
    • Collins, R.1    Armitage, J.2    Parish, S.3    Sleight, P.4    Peto5
  • 38
    • 2642547998 scopus 로고    scopus 로고
    • Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events
    • S. Greisenegger, M. Mullner, S. Tentschert, W. Lang, and W. Lalouschek Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events J Neurol Sci 221 2004 1 2
    • (2004) J Neurol Sci , vol.221 , pp. 1-2
    • Greisenegger, S.1    Mullner, M.2    Tentschert, S.3    Lang, W.4    Lalouschek, W.5
  • 39
    • 3242713612 scopus 로고    scopus 로고
    • Rising statin use and effect on ischemic stroke outcome
    • Yoon SS, Dambrosia J, Chalela J, et al., Rising statin use and effect on ischemic stroke outcome. BMC Med. Available at: http://www.pubmedcentral.nih. gov/articlerender.fcgi?tool = pubmed&pubmedid = 15035663. Accessed May 5, 2005.
    • BMC Med.
    • Yoon, S.S.1    Dambrosia, J.2    Chalela, J.3
  • 40
    • 12144275056 scopus 로고    scopus 로고
    • Expanding indications for statins in cerebral ischemia: A quantitative study
    • B. Ovbiagele, C.S. Kidwell, and J.L. Saver Expanding indications for statins in cerebral ischemia: a quantitative study Arch Neurol 62 2005 67 72
    • (2005) Arch Neurol , vol.62 , pp. 67-72
    • Ovbiagele, B.1    Kidwell, C.S.2    Saver, J.L.3
  • 41
    • 1842870796 scopus 로고    scopus 로고
    • Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    • S. Ruland, and P.B. Gorelick Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor? Curr Neurol Neurosci Rep 3 2003 21 26
    • (2003) Curr Neurol Neurosci Rep , vol.3 , pp. 21-26
    • Ruland, S.1    Gorelick, P.B.2
  • 43
    • 0038460302 scopus 로고    scopus 로고
    • The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 report
    • A. Chobanian, G.L. Bakris, and H.R. Blacj The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
    • (2003) JAMA , vol.289 , pp. 2560-2572
    • Chobanian, A.1    Bakris, G.L.2    Blacj, H.R.3
  • 44
    • 0035968623 scopus 로고    scopus 로고
    • Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
    • PROGRESS Collaborative Group
    • PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
    • (2001) Lancet , vol.358 , pp. 1033-1041
  • 45
    • 20044369896 scopus 로고    scopus 로고
    • Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) study
    • K. Wachtell, M. Lehto, and E. Gerdts Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study Am Coll Cardiol 45 2005 712 719
    • (2005) Am Coll Cardiol , vol.45 , pp. 712-719
    • Wachtell, K.1    Lehto, M.2    Gerdts, E.3
  • 46
    • 0038261970 scopus 로고    scopus 로고
    • Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. the ACCESS study: Evaluation of acute candesartan cilexetil therapy in stroke survivors
    • J. Schrader, S. Luders, and A. Kulschewski Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors Stroke 34 2003 1699 1703 Epub 2003
    • (2003) Stroke , vol.34 , pp. 1699-1703
    • Schrader, J.1    Luders, S.2    Kulschewski, A.3
  • 47
    • 3142775598 scopus 로고    scopus 로고
    • Evidence-based surgical treatment of carotid stenosis. Literature review
    • N. Andaluz, and M. Zuccarello Evidence-based surgical treatment of carotid stenosis. Literature review J Neurosurg Sci 48 2004 1 9
    • (2004) J Neurosurg Sci , vol.48 , pp. 1-9
    • Andaluz, N.1    Zuccarello, M.2
  • 48
    • 4344681517 scopus 로고    scopus 로고
    • Carotid revascularization for prevention of stroke: Carotid endarterectomy and carotid artery stenting
    • T.G. Brott, R.D. Brown Jr., F.B. Meyer, D.A. Miller, H.J. Cloft, and T.M. Sullivan Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting Mayo Clin Proc 79 2004 1197 1208
    • (2004) Mayo Clin Proc , vol.79 , pp. 1197-1208
    • Brott, T.G.1    Brown Jr., R.D.2    Meyer, F.B.3    Miller, D.A.4    Cloft, H.J.5    Sullivan, T.M.6
  • 49
    • 8544220369 scopus 로고    scopus 로고
    • Carotid artery surgery vs. stent: A cardiovascular perspective
    • I.A. Alhaddad Carotid artery surgery vs. stent: a cardiovascular perspective Cathet Cardiovasc Interv 63 2004 377 384
    • (2004) Cathet Cardiovasc Interv , vol.63 , pp. 377-384
    • Alhaddad, I.A.1
  • 50
    • 8844225629 scopus 로고    scopus 로고
    • Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients
    • A. Kastrup, J.B. Schulz, S. Raygrotzki, K. Groschel, and U. Ernemann Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients J Vasc Surg 40 2004 945 951
    • (2004) J Vasc Surg , vol.40 , pp. 945-951
    • Kastrup, A.1    Schulz, J.B.2    Raygrotzki, S.3    Groschel, K.4    Ernemann, U.5
  • 52
    • 0345714973 scopus 로고    scopus 로고
    • In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization
    • H.D. Aronow, G.M. Novaro, and M.S. Lauer In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization Arch Intern Med 163 2003 2576 2582
    • (2003) Arch Intern Med , vol.163 , pp. 2576-2582
    • Aronow, H.D.1    Novaro, G.M.2    Lauer, M.S.3
  • 53
    • 23244462552 scopus 로고    scopus 로고
    • The impact of standardized stroke orders on adherence to best practices
    • California Acute Stroke Pilot Registry Investigators The impact of standardized stroke orders on adherence to best practices Neurology 65 2005 360 365
    • (2005) Neurology , vol.65 , pp. 360-365


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.